contraindications for glp-1 agonists include Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus GLP-1 receptor agonists are transforming

In the LEAN trial, Liraglutide was shown to have a higher rates of NASH resolution and lower rates of fibrosis progression compared to placebo

Patients should be counselled to expect these potential side-effects

M.OnsteinJ.StohrR.JankowskiV.JankowskiJ.et al

The clinical trials excluded participants on certain medications, so comprehensive interaction data is limited

And now, people across the world are injecting a compound inspired by a desert predator to control hunger, regulate insulin, and reshape how modern medicine approaches weight and metabolism

It also reduces appetite by having a negative impact on GE and by enabling insulin release from the pancreas, acting in tandem with GLP-1 [26]